HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Online-Only Appendix All Versions of this Article: db07-1403v1 db07-1403v2 57/6/1470    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Cani, P. D. Articles by Burcelin, R. PubMed PubMed Citation Articles by Cani, P. D. Articles by Burcelin, R. Social Bookmarking                What's this?

Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice

¹ Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
² Rangueil Institute of Molecular Medicine, Toulouse, France
³ Nestlé Research Center, Department of Nutrition and Health, Lausanne, Switzerland

Corresponding author: Prof. Rémy Burcelin, Rangueil Institute of Molecular Medicine, I²MR, IFR31, Toulouse, France. E-mail: burcelin{at}toulouse.inserm.fr

Abbreviations: DGGE, denaturing gradient gel electrophoresis; FITC, fluorescein isothiocyanate; IL, interleukin; LPS, lipopolysaccharide; MDA, malondialdehyde; MCP, monocyte chemotactic protein; PAI-1, plasminogen activator inhibitor 1; RPL19, ribosomal protein L19; TBARS, thiobarbituric acid reactive substances; TNF-, tumor necrosis factor-; ZO-1, zonula occludens-1

OBJECTIVE—Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown. We previously determined, first, that metabolic endotoxemia controls the inflammatory tone, body weight gain, and diabetes, and second, that high-fat feeding modulates gut microbiota and the plasma concentration of lipopolysaccharide (LPS), i.e., metabolic endotoxemia. Therefore, it remained to demonstrate whether changes in gut microbiota control the occurrence of metabolic diseases.

RESEARCH DESIGN AND METHODS—We changed gut microbiota by means of antibiotic treatment to demonstrate, first, that changes in gut microbiota could be responsible for the control of metabolic endotoxemia, the low-grade inflammation, obesity, and type 2 diabetes and, second, to provide some mechanisms responsible for such effect.

RESULTS—We found that changes of gut microbiota induced by an antibiotic treatment reduced metabolic endotoxemia and the cecal content of LPS in both high-fat–fed and ob/ob mice. This effect was correlated with reduced glucose intolerance, body weight gain, fat mass development, lower inflammation, oxidative stress, and macrophage infiltration marker mRNA expression in visceral adipose tissue. Importantly, high-fat feeding strongly increased intestinal permeability and reduced the expression of genes coding for proteins of the tight junctions. Furthermore, the absence of CD14 in ob/ob CD14^–/– mutant mice mimicked the metabolic and inflammatory effects of antibiotics.

CONCLUSIONS—This new finding demonstrates that changes in gut microbiota controls metabolic endotoxemia, inflammation, and associated disorders by a mechanism that could increase intestinal permeability. It would thus be useful to develop strategies for changing gut microbiota to control, intestinal permeability, metabolic endotoxemia, and associated disorders.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?